SMI
12.339,76
PKT
+22,69
PKT
+0,18
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 02.02.05 | Roche Buy | Sarasin Research | |
| 02.02.05 | Swiss Life Overweight | JP Morgan | |
| 02.02.05 | Roche Halten | Helaba Trust | |
| 03.02.05 | Novartis Übergewichten | Reuschel & Co | |
| 03.02.05 | Roche Buy | Sarasin Research | |
| 01.02.05 | Zurich Insurance Buy | Sarasin Research | |
| 01.02.05 | Novartis Kaufen | SYZ & CO | |
| 01.02.05 | Roche Halten | Helaba Trust | |
| 01.02.05 | UBS Neutral | Merrill Lynch | |
| 01.02.05 | UBS Buy | Merrill Lynch | |
| 01.02.05 | UBS Buy | Sarasin Research | |
| 01.02.05 | Logitech Kauf | SYZ & CO | |
| 31.01.05 | Novartis Outperform | Credit Suisse First Boston | |
| 31.01.05 | Roche Buy | Sarasin Research | |
| 02.02.05 | UBS Outperform | Credit Suisse First Boston | |
| 31.01.05 | Nestlé Neutral | Sarasin Research | |
| 01.02.05 | Roche Neutral | Credit Suisse First Boston | |
| 31.01.05 | Lonza Reduce | Sarasin Research | |
| 31.01.05 | Novartis Buy | Helvea | |
| 28.01.05 | Holcim Verkaufen | Helaba Trust | |
| 27.01.05 | Lonza Buy | Helvea | |
| 03.02.05 | Novartis Outperformer | Sparkasse KölnBonn | |
| 27.01.05 | Holcim Halten | Helaba Trust | |
| 27.01.05 | Holcim Neutral | Helvea | |
| 26.01.05 | Novartis Market Perform | William Blair | |
| 26.01.05 | UBS Buy | Sarasin Research | |
| 26.01.05 | Lonza Reduce | Sarasin Research | |
| 25.01.05 | Holcim Accumulate | Helvea | |
| 25.01.05 | Novartis Halten | LB Baden-Württemberg | |
| 25.01.05 | UBS Buy | Helvea | |
| 25.01.05 | Lonza Overweight | JP Morgan | |
| 25.01.05 | Novartis Outperform | Goldman Sachs | |
| 26.01.05 | Nestlé Outperform | Credit Suisse First Boston | |
| 25.01.05 | Novartis Buy | Helvea | |
| 25.01.05 | Swisscom Underweight | Lehman Brothers | |
| 24.01.05 | Novartis Overweight | Prudential Securities | |
| 24.01.05 | Holcim Neutral | Sarasin Research | |
| 24.01.05 | Novartis Neutral | Sarasin Research | |
| 24.01.05 | Richemont Outperform | Goldman Sachs | |
| 25.01.05 | Novartis Neutral | Sarasin Research |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.